News & Event

News & Event

Drug screening platform
2018/3/4

Drug screening platform related publications: click "more" for detailed information !

1. Shen Y, Dana H, Abdelfattah AS, Patel R, Shea J, Molina RS, Rawal B, Rancic V, Chang YF, Wu L,Chen Y, Qian Y, Wiens MD, Hambleton N, Ballanyi K, Hughes TE, Drobizhev M, Kim DS,Koyama M, Schreiter ER, Campbell RE. A genetically encoded Ca(2+) indicator based on circularly permutated sea anemone red fluorescent protein eqFP578. BMC Biol. 2018 Jan 16;16(1):9.
2. Shen Y, Dana H, Abdelfattah A, Patel R, Shea J, Molina R, Rawal B, Rancic V, Chang YF., et al A genetically encoded Ca2+ indicator based on circularly permutated sea anemone red fluorescent protein. (preprint on bioRxiv,doi: https://doi.org/10.1101/213082)
3. Chang YF, Broyles CN, Brook FA, Davies MJ, Turtle CW, Nagai T, Daniels MJ. Non-invasive phenotyping and drug testing in single cardiomyocytes or beta-cells by calcium imaging and optogenetics. PLoS One. 2017 Apr 5;12(4):e0174181
4. Wu J, Liu L, Matsuda T, Zhao Y, Rebane A, Drobizhev M, Chang YF, Araki S, Arai Y, March K, Hughes TE, Sagou K, Miyata T, Nagai T, Li WH, Campbell RE. Improved orange and red Ca²± indicators and photophysical considerations for optogenetic applications. ACS Chem Neurosci. 2013 Jun 19;4(6):963-72.
5. Chang YF, Arai Y, Nagai T. Optogenetic activation during “dead-time” of detector enables well compatible fluorescence imaging with increasing time resolution and reducing background noise. Neurosci Res. 73(4): 341–347, 2012.
6. Saito K*, Chang YF*, Horikawa K*, Hatsugai N*, Higuchi Y, Hashida M, Yoshida Y, Matsuda T, Arai Y, Nagai T. Luminescent proteins for high-speed single-cell and whole-body imaging. Nat Commun. 2012;3:1262.
7. Zhao Y, Araki S, Wu J, Teramoto T, Chang YF, Nakano M, Abdelfattah AS, Fujiwara M, Ishihara T, Nagai T, Campbell RE. An expanded palette of genetically encoded Ca²⁺ indicators. Science. 2011
Sep 30;333(6051):1888-91.

< 1 >